Correlation Between Mereo BioPharma and Mesoblast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Mesoblast, you can compare the effects of market volatilities on Mereo BioPharma and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Mesoblast.

Diversification Opportunities for Mereo BioPharma and Mesoblast

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mereo and Mesoblast is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Mesoblast go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Mesoblast

Given the investment horizon of 90 days Mereo BioPharma is expected to generate 1.56 times less return on investment than Mesoblast. But when comparing it to its historical volatility, Mereo BioPharma Group is 1.8 times less risky than Mesoblast. It trades about 0.07 of its potential returns per unit of risk. Mesoblast is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  732.00  in Mesoblast on October 25, 2024 and sell it today you would earn a total of  1,026  from holding Mesoblast or generate 140.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.58%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Mesoblast

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Mesoblast 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Mereo BioPharma and Mesoblast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Mesoblast

The main advantage of trading using opposite Mereo BioPharma and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.
The idea behind Mereo BioPharma Group and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk